Paul M Ridker, MD, MPH

Paul M Ridker, MD, MPH

Harvard University

H-index: 273

North America-United States

About Paul M Ridker, MD, MPH

Paul M Ridker, MD, MPH, With an exceptional h-index of 273 and a recent h-index of 163 (since 2020), a distinguished researcher at Harvard University,

His recent articles reflect a diverse array of research interests and contributions to the field:

N-Glycosylation Profiles of Immunoglobulin G and Future Cardiovascular Events

Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial Infarction

Effect of canakinumab on frailty: A post hoc analysis of the CANTOS trial

Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis

Use of canakinumab

Effect of CSL112 on Recurrent Myocardial Infarction and Cardiovascular Death: Insights from the AEGIS-II Trial

Plasma Biomarker Profiles for Premature and Nonpremature Coronary Heart Disease in Women

Multi-trait analysis characterizes the genetics of thyroid function and identifies causal associations with clinical implications

Paul M Ridker, MD, MPH Information

University

Harvard University

Position

Eugene Braunwald Professor of Medicine, Harvard Medical School

Citations(all)

459679

Citations(since 2020)

143122

Cited By

358473

hIndex(all)

273

hIndex(since 2020)

163

i10Index(all)

1087

i10Index(since 2020)

791

Email

University Profile Page

Harvard University

Top articles of Paul M Ridker, MD, MPH

Title

Journal

Author(s)

Publication Date

N-Glycosylation Profiles of Immunoglobulin G and Future Cardiovascular Events

Circulation Research

Rosangela A Hoshi

Branimir Plavša

Yanyan Liu

Irena Trbojević-Akmačić

Robert J Glynn

...

2024/2/13

Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial Infarction

New England Journal of Medicine

C Michael Gibson

Danielle Duffy

Serge Korjian

M Cecilia Bahit

Gerald Chi

...

2024/4/6

Effect of canakinumab on frailty: A post hoc analysis of the CANTOS trial

Aging Cell

Ariela R Orkaby

Aerin Thomson

Jean MacFadyen

Richard Besdine

Daniel E Forman

...

2024/1

Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis

The Lancet Diabetes & Endocrinology

Christina Reith

David Preiss

Lisa Blackwell

Jonathan Emberson

Enti Spata

...

2024/5/1

Use of canakinumab

2024/2/8

Effect of CSL112 on Recurrent Myocardial Infarction and Cardiovascular Death: Insights from the AEGIS-II Trial

Journal of the American College of Cardiology

Thomas J Povsic

Serge Korjian

M Cecilia Bahit

Gerald Chi

Danielle Duffy

...

2024/4/6

Plasma Biomarker Profiles for Premature and Nonpremature Coronary Heart Disease in Women

Clinical Chemistry

Sagar B Dugani

M Vinayaga Moorthy

Olga V Demler

Chunying Li

Paul M Ridker

...

2024/5

Multi-trait analysis characterizes the genetics of thyroid function and identifies causal associations with clinical implications

Nature Communications

Rosalie BTM Sterenborg

Inga Steinbrenner

Yong Li

Melissa N Bujnis

Tatsuhiko Naito

...

2024/1/30

Prioritization of Kidney Cell Types Highlights Myofibroblast Cells in Regulating Human Blood Pressure

Kidney International Reports

Mahboube Ganji-Arjenaki

Zoha Kamali

Evangelos Evangelou

Helen R Warren

He Gao

...

2024/3/13

Genome-wide analysis in over 1 million individuals of European ancestry yields improved polygenic risk scores for blood pressure traits

Helen Warren

Todd Edwards

Ahmad Vaez

Jacob Keaton

Zoha Kamali

...

2022/3/10

X-chromosome and kidney function: evidence from a multi-trait genetic analysis of 908,697 individuals reveals sex-specific and sex-differential findings in genes regulated by …

Nature Communications

Markus Scholz

Katrin Horn

Janne Pott

Matthias Wuttke

Andreas Kühnapfel

...

2024/1/18

Prediction of individual lifetime cardiovascular risk and potential treatment benefit: development and recalibration of the LIFE-CVD2 model to four European risk regions

European Journal of Preventive Cardiology

Steven H Hageman

Stephen Kaptoge

Tamar I de Vries

Wentian Lu

Janet M Kist

...

2024/3/13

Low-dose colchicine for atherosclerosis: long-term safety

Stefan Mark Nidorf

Eldad Ben-Chetrit

Paul M Ridker

2024/4/10

Inflammation and Cholesterol as Predictors of Cardiovascular Events Among 13 970 Contemporary High-Risk Patients With Statin Intolerance

Circulation

Paul M Ridker

Lei Lei

Michael J Louie

Tariq Haddad

Stephen J Nicholls

...

2024/1/2

Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV: Mechanistic Substudy of the REPRIEVE Randomized Clinical Trial

JAMA cardiology

Michael T Lu

Heather Ribaudo

Borek Foldyna

Markella V Zanni

Thomas Mayrhofer

...

2024/2/21

A Technology-Assisted Web Application for Consumer Access to a Nonprescription Statin Medication

Journal of the American College of Cardiology

Steven E Nissen

Howard G Hutchinson

Kathy Wolski

Karol Watson

Seth S Martin

...

2024/4/8

HERMES: Effects Of Ziltivekimab Versus Placebo On Morbidity And Mortality In Patients With Heart Failure With Mildly Reduced Or Preserved Ejection Fraction And Systemic …

Journal of Cardiac Failure

Mark Petrie

Barry Borlaug

Kristine Buchholtz

Anique Ducharme

Anders Hvelplund

...

2024/1/1

The Mediterranean Diet, Cardiometabolic Biomarkers, and Risk of All-Cause Mortality: A 25-Year Follow-Up Study of the Women’s Health Study

medRxiv

Shafqat Ahmad

M Vinayaga Moorthy

I-Min Lee

Paul M Ridker

JoAnn E Manson

...

2023/10/3

Gene-educational attainment interactions in a multi-population genome-wide meta-analysis identify novel lipid loci

Molecular psychiatry

Lisa de Las Fuentes

Yun Ju Sung

Raymond Noordam

Thomas Winkler

Mary F Feitosa

...

2021/6

The power of genetic diversity in genome-wide association studies of lipids (vol 600, pg 675, 2021)

Nature

Sarah E Graham

Shoa L Clarke

Kuan-Han H Wu

Stavroula Kanoni

Greg JM Zajac

...

2023/5/26

See List of Professors in Paul M Ridker, MD, MPH University(Harvard University)

Paul M Ridker, MD, MPH FAQs

What is Paul M Ridker, MD, MPH's h-index at Harvard University?

The h-index of Paul M Ridker, MD, MPH has been 163 since 2020 and 273 in total.

What are Paul M Ridker, MD, MPH's top articles?

The articles with the titles of

N-Glycosylation Profiles of Immunoglobulin G and Future Cardiovascular Events

Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial Infarction

Effect of canakinumab on frailty: A post hoc analysis of the CANTOS trial

Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis

Use of canakinumab

Effect of CSL112 on Recurrent Myocardial Infarction and Cardiovascular Death: Insights from the AEGIS-II Trial

Plasma Biomarker Profiles for Premature and Nonpremature Coronary Heart Disease in Women

Multi-trait analysis characterizes the genetics of thyroid function and identifies causal associations with clinical implications

...

are the top articles of Paul M Ridker, MD, MPH at Harvard University.

What is Paul M Ridker, MD, MPH's total number of citations?

Paul M Ridker, MD, MPH has 459,679 citations in total.